Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Ophthalmology

ISSN

2218-6239

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Ophthalmol. Aug 12, 2014; 4(3): 75-81
Published online Aug 12, 2014. doi: 10.5318/wjo.v4.i3.75

Full Size Figure Download Figure

Figure 3 The percentage of intraoperative complications.

Citation: Ferreira MA, Ferreira REA, Silva NS. Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy. World J Ophthalmol 2014; 4(3): 75-81
URL: https://www.wjgnet.com/2218-6239/full/v4/i3/75.htm
DOI: https://dx.doi.org/10.5318/wjo.v4.i3.75

Ferreira MA, Ferreira REA, Silva NS. Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy. World J Ophthalmol 2014; 4(3): 75-81 [DOI: 10.5318/wjo.v4.i3.75]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.